1-15 of 15
Randy D. Gascoyne
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408

Available to Purchase
Andrew M. Evens, Fangxin Hong, Thomas M. Habermann, Ranjana H. Advani, Randy D. Gascoyne, Thomas E. Witzig, Andrew Quon, Erik A. Ranheim, Stephen M. Ansell, Puneet Singh Cheema, Philip A. Dy, Timothy E. O'Brien, Jane N. Winter, Terrence P. Cescon, Julie E. Chang, Brad S. Kahl
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (17): 4468–4477.
https://doi.org/10.1158/1078-0432.CCR-20-1345
Published: 01 September 2020
View articletitled, A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408
Open the PDF for A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408 in another window
Includes: Supplementary data
Journal Articles

A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Free
Myron S. Czuczman, Marek Trněný, Andrew Davies, Simon Rule, Kim M. Linton, Nina Wagner-Johnston, Randy D. Gascoyne, Graham W. Slack, Pierre Brousset, David A. Eberhard, Francisco J. Hernandez-Ilizaliturri, Gilles Salles, Thomas E. Witzig, Pier Luigi Zinzani, George W. Wright, Louis M. Staudt, Yandan Yang, P. Mickey Williams, Chih-Jian Lih, Jacqueline Russo, Anjan Thakurta, Patrick Hagner, Pierre Fustier, Dale Song, Ian D. Lewis
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (15): 4127–4137.
https://doi.org/10.1158/1078-0432.CCR-16-2818
Published: 01 August 2017
View articletitled, A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Open the PDF for A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Toward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T Cells

Free
Julie S. Nielsen, Colin G. Sedgwick, Aniqa Shahid, Zusheng Zong, Zabrina L. Brumme, Stephen Yu, Lewis Liu, David R. Kroeger, Steven P. Treon, Joseph M. Connors, Randy D. Gascoyne, Brian R. Berry, Marco A. Marra, Ryan D. Morin, Nicol Macpherson, Brad H. Nelson
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (9): 2226–2236.
https://doi.org/10.1158/1078-0432.CCR-15-2023
Published: 01 May 2016
View articletitled, Toward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T Cells
Open the PDF for Toward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T Cells in another window
Includes: Supplementary data
Journal Articles

Fc Gamma Receptor 3A and 2A Polymorphisms Do Not Predict Response to Rituximab in Follicular Lymphoma

Free
Vaishalee P. Kenkre, Fangxin Hong, James R. Cerhan, Marcia Lewis, Leslie Sullivan, Michael E. Williams, Randy D. Gascoyne, Sandra J. Horning, Brad S. Kahl
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (4): 821–826.
https://doi.org/10.1158/1078-0432.CCR-15-1848
Published: 14 February 2016
View articletitled, Fc Gamma Receptor 3A and 2A Polymorphisms Do Not Predict Response to Rituximab in Follicular Lymphoma
Open the PDF for Fc Gamma Receptor 3A and 2A Polymorphisms Do Not Predict Response to Rituximab in Follicular Lymphoma in another window
Journal Articles

Abstract PR5: Prediction of survival in diffuse large B-cell lymphoma based on the expression of two genes integrating tumor and microenvironment

Free
Andrew J. Gentles, Ash A. Alizadeh, Alvaro J. Alencar, Holbrook E. Kohrt, Roch Houot, Matthew J. Goldstein, Yasodha Natkunam, Ranjana H. Advani, Randy D. Gascoyne, Javier Briones, Sylvia K. Plevritis, Izidore S. Lossos, Ronald Levy
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (14_Supplement): PR5.
https://doi.org/10.1158/1078-0432.TCMUSA10-PR5
Published: 02 February 2016
View articletitled, Abstract PR5: Prediction of survival in diffuse large B-cell lymphoma based on the expression of two genes integrating tumor and microenvironment
Journal Articles

Abstract A19: MALT1 inhibition as an anchor for combinatorial therapy of ABC-DLBCL.

Free
Lorena Fontan, Chenghua Yang, Himaly Shinglot, Venkataraman Kabaleeswaran, Volpon Laurent, Michael Osborne, Elena Beltran, Monica Rosen, Rita Shaknovich, Shao N. Yang, Randy D. Gascoyne, Leandro Cerchietti, Jose A. MArtinez-Climent, J Fraser Glickman, KAtherine Borden, Hao Wu, Ari Melnick
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (17_Supplement): A19.
https://doi.org/10.1158/1557-3265.HEMMAL14-A19
Published: 19 August 2015
View articletitled, Abstract A19: MALT1 inhibition as an anchor for combinatorial therapy of ABC-DLBCL.
Journal Articles

The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association

Free
Robert Kridel, Luc Xerri, Bénédicte Gelas-Dore, King Tan, Pierre Feugier, Ayesha Vawda, Danielle Canioni, Pedro Farinha, Sami Boussetta, Alden A. Moccia, Pauline Brice, Elizabeth A. Chavez, Alastair H. Kyle, David W. Scott, Ashley D. Sanders, Bettina Fabiani, Graham W. Slack, Andrew I. Minchinton, Corinne Haioun, Joseph M. Connors, Laurie H. Sehn, Christian Steidl, Randy D. Gascoyne, Gilles Salles
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (15): 3428–3435.
https://doi.org/10.1158/1078-0432.CCR-14-3253
Published: 02 August 2015
View articletitled, The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association
Open the PDF for The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association in another window
Includes: Supplementary data
Journal Articles

Bromodomain Inhibition in Diffuse Large B-cell Lymphoma—Giving MYC a Brake

Free
Anja Mottok, Randy D. Gascoyne
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (1): 4–6.
https://doi.org/10.1158/1078-0432.CCR-14-1651
Published: 05 January 2015
View articletitled, Bromodomain Inhibition in Diffuse Large B-cell Lymphoma—Giving MYC a Brake
Open the PDF for Bromodomain Inhibition in Diffuse Large B-cell Lymphoma—Giving MYC a Brake in another window
Journal Articles

BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab

Free
Javeed Iqbal, Paul N. Meyer, Lynette M. Smith, Nathalie A. Johnson, Julie M. Vose, Timothy C. Greiner, Joseph M. Connors, Louis M. Staudt, Lisa Rimsza, Elaine Jaffe, Andreas Rosenwald, German Ott, Jan Delabie, Elias Campo, Rita M. Braziel, James R. Cook, Raymond R. Tubbs, Randy D. Gascoyne, James O. Armitage, Dennis D. Weisenburger, Wing C. Chan
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (24): 7785–7795.
https://doi.org/10.1158/1078-0432.CCR-11-0267
Published: 18 December 2011
View articletitled, BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab
Open the PDF for BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab in another window
Includes: Supplementary data
Journal Articles

MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP

Free
Alvaro J. Alencar, Raquel Malumbres, Goldi A. Kozloski, Ranjana Advani, Neha Talreja, Shideh Chinichian, Javier Briones, Yasodha Natkunam, Laurie H. Sehn, Randy D. Gascoyne, Rob Tibshirani, Izidore S. Lossos
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 4125–4135.
https://doi.org/10.1158/1078-0432.CCR-11-0224
Published: 15 June 2011
View articletitled, MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP
Open the PDF for MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP in another window
Includes: Supplementary data
Journal Articles

Accurate Classification of Diffuse Large B-Cell Lymphoma into Germinal Center and Activated B-Cell Subtypes Using a Nuclease Protection Assay on Formalin-Fixed, Paraffin-Embedded Tissues

Free
Lisa M. Rimsza, George Wright, Mark Schwartz, Wing C. Chan, Elaine S. Jaffe, Randy D. Gascoyne, Elias Campo, Andreas Rosenwald, German Ott, James R. Cook, Raymond R. Tubbs, Rita M. Braziel, Jan Delabie, Tom P. Miller, Louis M. Staudt
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (11): 3727–3732.
https://doi.org/10.1158/1078-0432.CCR-10-2573
Published: 01 June 2011
View articletitled, Accurate Classification of Diffuse Large B-Cell Lymphoma into Germinal Center and Activated B-Cell Subtypes Using a Nuclease Protection Assay on Formalin-Fixed, Paraffin-Embedded Tissues
Open the PDF for Accurate Classification of Diffuse Large B-Cell Lymphoma into Germinal Center and Activated B-Cell Subtypes Using a Nuclease Protection Assay on Formalin-Fixed, Paraffin-Embedded Tissues in another window
Journal Articles

Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494

Free
Jane N. Winter, Shuli Li, Vikas Aurora, Daina Variakojis, Beverly Nelson, Maryla Krajewska, Lijun Zhang, Thomas M. Habermann, Richard I. Fisher, William R. Macon, Mukesh Chhanabhai, Raymond E. Felgar, Eric D. Hsi, L. Jeffrey Medeiros, James K. Weick, Edie A. Weller, Ari Melnick, John C. Reed, Sandra J. Horning, Randy D. Gascoyne
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (8): 2435–2442.
https://doi.org/10.1158/1078-0432.CCR-09-1219
Published: 14 April 2010
View articletitled, Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494
Open the PDF for Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494 in another window
Includes: Supplementary data
Journal Articles

A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

Free
William W.L. Choi, Dennis D. Weisenburger, Timothy C. Greiner, Miguel A. Piris, Alison H. Banham, Jan Delabie, Rita M. Braziel, Huimin Geng, Javeed Iqbal, Georg Lenz, Julie M. Vose, Christine P. Hans, Kai Fu, Lynette M. Smith, Min Li, Zhongfeng Liu, Randy D. Gascoyne, Andreas Rosenwald, German Ott, Lisa M. Rimsza, Elias Campo, Elaine S. Jaffe, David L. Jaye, Louis M. Staudt, Wing C. Chan
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (17): 5494–5502.
https://doi.org/10.1158/1078-0432.CCR-09-0113
Published: 31 August 2009
View articletitled, A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
Open the PDF for A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy in another window
Includes: Supplementary data
Journal Articles

Expression of the FOXP1 Transcription Factor Is Strongly Associated with Inferior Survival in Patients with Diffuse Large B-Cell Lymphoma

Free
Alison H. Banham, Joseph M. Connors, Philip J. Brown, Jacqueline L. Cordell, German Ott, Gayatri Sreenivasan, Pedro Farinha, Douglas E. Horsman, Randy D. Gascoyne
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (3): 1065–1072.
https://doi.org/10.1158/1078-0432.1065.11.3
Published: 11 February 2005
View articletitled, Expression of the FOXP1 Transcription Factor Is Strongly Associated with Inferior Survival in Patients with Diffuse Large B-Cell Lymphoma
Open the PDF for Expression of the FOXP1 Transcription Factor Is Strongly Associated with Inferior Survival in Patients with Diffuse Large B-Cell Lymphoma in another window
Journal Articles

Eradication of Human Non-Hodgkin’s Lymphoma in SCID Mice by BCL-2 Antisense Oligonucleotides Combined with Low-Dose Cyclophosphamide

Free
Richard J. Klasa, Marcel B. Bally, Rebecca Ng, James H. Goldie, Randy D. Gascoyne, Frances M. P. Wong
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (6): 2492–2500.
Published: 01 June 2000
View articletitled, Eradication of Human Non-Hodgkin’s Lymphoma in SCID Mice by BCL-2 Antisense Oligonucleotides Combined with Low-Dose Cyclophosphamide
Open the PDF for Eradication of Human Non-Hodgkin’s Lymphoma in SCID Mice by BCL-2 Antisense Oligonucleotides Combined with Low-Dose Cyclophosphamide in another window